Physician profile
Mhamad Faour
NPI 1548746514
$1,605.48
in general payments reported to CMS, 2019-2025
11 companies · $1,030 in 2025
The $1,030 reported for 2025 was more than what 88% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $47.60 · 2024: $528 · 2025: $1,030.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,149 · Education: $408.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,149.39 |
| Education | $408.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $408.49 | 2024-2025 | Actis, Mentor Memorygel Resterilizable Gel Sizer, Mentor Memorygel Breast Implant |
| Stryker Corporation | $244.74 | 2025 | Na |
| Davol INC. | $153.55 | 2025 | Arista |
| Acera Surgical, INC. | $152.96 | 2024 | Restrata Wound Matrix |
| Polynovo North America LLC | $144.46 | 2024 | Novosorb Btm |
| Integra Lifesciences Corporation | $135.52 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Abbvie INC. | $129.47 | 2025 | |
| W. L. Gore & Associates, INC. | $103.02 | 2024 | Gore Tag Thoracic Branch Endoprosthesis |
| Kerecis Limited | $67.73 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Medtronic, INC. | $47.60 | 2022 | |
| Crossroads Orthopedics, LLC | $17.94 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mhamad Faour listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.